Depletion of Hepatic SREBP2 Protects Against Hypercholesterolemia and Atherosclerosis through the ANGPTL3‐LPL Axis
Advanced Science · 2025-05 · 12 (18)
DOI: 10.1002/advs.202412677 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 19.03.2025. Verfasst von Yifan Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117596, Singapore. Hauptthemen laut MEDLINE: Sterol Regulatory Element Binding Protein 2, Atherosclerosis, Liver, Hypercholesterolemia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National University of Singapore, Singapore National Medical Research Council.
Abstract (Originalsprache)
Lipolysis of triglyceride‐rich lipoproteins by peripheral lipoprotein lipase (LPL) plays an essential role in maintaining systemic cholesterol/lipid homeostasis. Human genetic studies have unequivocally demonstrated that activation of LPL pathway reduces risks for both coronary artery disease (CAD) and type 2 diabetes (T2D). Although sterol regulatory element‐binding protein 2 (SREBP2) is well established as the master transcription factor that regulates the hepatic biosynthesis of both cholesterol and fatty acids, whether and how its activity in liver interacts with peripheral LPL pathway remains unknown. Here, it is demonstrated that acute liver‐specific depletion of SREBP2 results in divergent effects on the regulation of peripheral LPL activity in mice, depending on the presence or absence of low‐density lipoprotein receptors (LDLR). SREBP2 deficiency drastically elevates peripheral LPL activity through downregulation of plasma angiopoietin‐related protein 3 (ANGPTL3) levels in LDLR‐deficient mice. Moreover, in addition to SREBP2's transcriptional regulation of ANGPTL3, it is found that SREBP2 promotes proteasome‐based degradation of ANGPTL3 in the presence of LDLR. Remarkably, acute depletion of hepatic SREBP2 protects against hypercholesterolemia and atherosclerosis, in which atherosclerotic lesions are reduced by 45% compared to control littermates. Taken together, these findings outline a liver‐peripheral crosstalk mediated by SREBP2‐ANGPTL3‐LPL axis and suggest that SREBP2 inhibition can be an effective strategy to tackle homozygous familial hypercholesterolemia (HoFH).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117596, Singapore.
- Precision Medicine Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117596, Singapore.
- Cardiovascular Metabolic Disease Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore.
- Institute of Molecular and Cell Biology, A*STAR, Singapore, 138673, Singapore.
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore.
ORCID-Profile: Yifan Wang, Haojie Yu
Förderung
- National University of Singapore
- Singapore National Medical Research Council
Zitieren
APA
Wang, Y., Choe, J. Y. S., Shi, Y., Thi, T. T., Cao, X., Hu, Y., Cheng, K. Y., Li, H., Ji, Y., Liu, Y., Ackers-Johnson, M., Foo, R. S. Y., Shen, Y., & Yu, H. (2025). Depletion of Hepatic SREBP2 Protects Against Hypercholesterolemia and Atherosclerosis through the ANGPTL3‐LPL Axis. Advanced Science, 12(18). https://doi.org/10.1002/advs.202412677
Vancouver
Wang Y, Choe JYS, Shi Y, Thi TT, Cao X, Hu Y, et al. Depletion of Hepatic SREBP2 Protects Against Hypercholesterolemia and Atherosclerosis through the ANGPTL3‐LPL Axis. Advanced Science. 2025;12(18). doi:10.1002/advs.202412677
BibTeX
@article{Wang2025,
author = {Wang, Yifan and Choe, Jia You Sarafina and Shi, Yu and Thi, Thi Tun and Cao, Xiaoyun and Hu, Yang and Cheng, Kai Yan and Li, Hui and Ji, Yang and Liu, Yan and Ackers-Johnson, Matthew and Foo, Roger S Y and Shen, Yujia and Yu, Haojie},
title = {Depletion of Hepatic SREBP2 Protects Against Hypercholesterolemia and Atherosclerosis through the ANGPTL3‐LPL Axis},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {18},
doi = {10.1002/advs.202412677}
}
EUVIMED